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Self-reported disability in performing daily life activities was assessed in adults with severe obesity (BMI ≥ 35 kg/m2) using the
Health Assessment Questionnaire (HAQ). 262 participants were recruited into three BMI groups: Group I: 35–39.99 kg/m2; Group
II: 40–44.99 kg/m2; Group III: ≥45.0 kg/m2. Progressively increasing HAQ scores were documented with higher BMI; Group I
HAQ score: 0.125 (median) (range: 0–1.75); Group II HAQ score: 0.375 (0–2.5); Group III HAQ score: 0.75 (0–2.65) (Group
III versus II P < 0.001; Group III versus I P < 0.001; Group II versus I P = 0.004). HAQ score strongly correlated with BMI
and age. Nearly three-fourths of the study participants reported some degree of disability (HAQ score > 0). The prevalence of
this degree of disability increased with increasing BMI and age. It also correlated to type 2 diabetes, metabolic syndrome, and
clinical depression, but not to gender. Our data suggest that severe obesity is associated with self-reported disability in performing
common daily life activities, with increasing degree of disability as BMI increases over 35 kg/m2. Functional assessment is crucial
in obesity management, and establishing the disability profiles of obese patients is integral to both meet the specific healthcare
needs of individuals and develop evidence-based public health programs, interventions, and priorities.
1. Introduction
Obesity is the most frequent metabolic disease worldwide
and can progressively lead to a spectrum of comorbidities,
including type 2 diabetes, hypertension, dyslipidaemia, car-
diovascular disease, liver dysfunction, and osteoarthritis [1–
3]. Preventing obesity-related co-morbidity relies on effective
weight loss interventions; however, it is becoming evident
that there is also a further need to focus on the daily
living and well-being of obese patients. Obesity is still
associated with high early mortality, but advances in the
treatment of cardiovascular risk factors and acute coronary
syndromes are now offering better cardioprotection options
and prolong life expectancy [4]. Current data support the
notion that in developed societies an increasing number of
obese patients are expected to live more than previously
estimated, despite failing to reduce their body weight [4, 5].
Furthermore, demographic and epidemiological projections
predict growing and progressively ageing obese populations
in the Western world [6–8]. These populations are expected
to exhibit an escalating burden of obesity-related disease,
particularly regarding complications which were previously
underestimated or underexpressed due to earlier mortality,
such as mobility problems and disability [9].
Longstanding and/or progressive obesity can eventually
impair the physical ability of the patient to function in
everyday life. Obesity-associated disability has been shown
to correlate with body mass index (BMI) and the presence
of comorbidities [4, 10–13]. Difficulty to perform simple
everyday tasks (e.g., walking, climbing steps, driving, and
dressing) may complicate the daily life of obese patients to
the extent of inability to engage in usual social activities
and employment [4]. The consequent impact on quality of
life is devastating and may lead to a vicious cycle where
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obesity progressively causes physical inactivity, functional
limitations, and mental distress (e.g., anxiety, depression)
and vice versa [14, 15].
Furthermore, the economic burden posed by obesity-
related disability on healthcare systems is alarming with
reports suggesting that relative medical spending for the
obese may be up to 100% higher than for normal-weight
adults [16–18]. Evidence from the World Health Report
shows that overweight and obesity is responsible for 8–15%
of disability-adjusted life years lost in Europe and North
America [19]. Notably, data from the National Longitudinal
Survey of Youth in the USA indicate that being obese
raises the probability of receiving disability income by 6.92
percentage points for men and by 5.64 percentage points for
women, which is the equivalent to the effect of losing 15.9
and 16.7 years of education, respectively [16, 20].
Investigating the relationship between obesity and dis-
ability, identifying individuals at greater risk and improving
their functional capacity are increasingly recognised as
important steps in the care of obese patients. We present an
observational study aimed to explore associations between
increasing BMI and self-reported disability in adults with
severe obesity.
2. Patients and Methods
The study cohort was recruited from adults with BMI
≥35 kg/m2 followed at specialist outpatient obesity clinics at
the Warwickshire Institute of Diabetes, Endocrinology and
Metabolism (WISDEM, University Hospitals of Coventry
and Warwickshire NHS Trust) and at the Birmingham
Heartlands Hospital (Heart of England NHS Foundation
Trust). Exclusion criteria included obesity secondary to
endocrine or systemic disease (e.g., Cushing’s syndrome) and
disability attributed to systemic disease other than obesity
(e.g., rheumatoid arthritis, neurological disorders) or to
previous injuries/accidents. Patients with disability due to
further secondary complications of cardiometabolic disease
(e.g., diabetic foot ulcers, symptomatic diabetic neuropathy,
Charcot’s arthropathy, symptomatic ischemic heart disease,
and heart failure) were also excluded. The study was
approved by the local ethics committee, and all participants
provided informed consent. A total of 262 patients (183
females/79 males; mean age: 44.9 ± 10.5 years) completed
the study questionnaire, and all data were collected according
to protocol, including demographic and comorbidity data
obtained from reviewing the patients’ medical charts.
2.1. Assessments
2.1.1. Anthropometry. Body weight and height were mea-
sured at the outpatient obesity clinics in participants without
shoes and heavy clothing. Weight was measured to the
nearest 0.5 kg using a digital platform scale suitable for
morbidly obese patients with a capacity of 300 kg (Seca
675, Seca, Hamburg, Germany). The Harpenden stadiometer
was used to measure height to the nearest 0.1 cm. BMI
was calculated as body weight in kilograms divided by the
square of the height in meters. For the purposes of this
study participants were categorized into three BMI groups:
Group I: 35–39.99 kg/m2; Group II: 40–44.99 kg/m2; Group
III: ≥45.0 kg/m2.
2.1.2. Health Assessment Questionnaire. The Stanford Health
Assessment Questionnaire (HAQ) was used as a validated
self-report measure of functional ability in daily life [21, 22].
The HAQ has been widely applied in research, and, although
initially developed for use in rheumatology, it is considered
a generic instrument rather than disease specific [22–24].
Briefly, disability is assessed by the HAQ disability index
through 20 questions regarding the degree of difficulty in
performing two or three specific activities in eight distinct
categories. These categories are (1) dressing and grooming;
(2) arising; (3) eating; (4) walking; (5) hygiene; (6) reach;
(7) grip; (8) common daily activities. Four possible grades
of difficulty are provided for answering each question, which
are rated as “Without ANY Difficulty,” “With SOME Diffi-
culty,” “With MUCH Difficulty,” and “UNABLE To do” and
are assigned a score of 0, 1, 2, and 3, respectively. In addition,
each category has a companion variable for aids/devices that
documents if any type(s) of assistance is required for the
respective daily activities. For these variables the patient is
also asked to report whether he/she (1) needs no assistance;
(2) uses a special device in his/her daily activities; (3) usually
needs help from another person; or (4) usually needs both
a special device and help from another person. A complete
copy of the instrument and instructions on its use can be
downloaded from http://aramis.stanford.edu. Provided that
the participant has given answers for at least six categories,
the average score of the completed categories determines
the final HAQ score (Standard HAQ disability index score)
which ranges from 0 to 3 (0: no functional disability;
3: worst functional disability). Because healthy individuals
consistently score zero on the HAQ [23], for the purposes
of this study participants were also divided based on their
final HAQ score to patients with no disability (HAQ score:
0) and patients with at least some degree of disability (HAQ
score > 0).
2.1.3. Self-Reported Difficulty in Standing and Walking. Inde
-pendently of the HAQ, participants were also asked about
having difficulty: (1) in standing unaided for 2 to 3 minutes
and (2) in walking more than 100 metres (if necessary
with aids). Four possible grades of difficulty were provided
for each of these two questions: “Without ANY Difficulty,”
“With SOME Difficulty,” “With MUCH Difficulty,” and
“UNABLE To do,” assigned a score of 0, 1, 2, and 3,
respectively. For the purposes of this aspect of the study
participants were dichotomised based on their responses
regarding difficulty in standing and in walking more than 100
metres to either having no difficulty (score = 0) or having at
least some difficulty (score > 0).
2.2. Statistical Analysis. The Statistical Package for the
Social Sciences, SPSS, version 17.0 (SPSS Inc, Chicago, IL,
USA) was used to analyze data. Results are expressed as
percentage, mean ± standard deviation or median (range).
The Kolmogorov-Smirnov and the Shapiro-Wilk tests were
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used to determine whether each study variable had a
normal distribution. Based on these tests, BMI and HAQ
score distributions in this study were nonparametric. Thus,
comparisons between study groups were performed with
the Mann-Whitney U-test or the Kruskal-Wallis test, and
correlations were tested by the Spearman’s rank correlation
coefficient. Prevalence rates of disability between patient
groups were compared and tested for statistical significance
by chi-square test. Logistic regression was applied to test the
relation of disability with various covariates. A P value of
<0.05 was considered statistically significant.
3. Results
A total of 262 obese patients consented to participate in the
study out of 434 patients that were invited to participate,
representing a 60% response rate (183 female (F) and 79 male
(M) patients; with approximately 61.5% and 58% response
rate in women and men, resp.). Mean age of the study
participants was 44.9 ± 10.5 years (women: 44.2 ± 10.5
years; men: 46.7 ± 10.4 years), with a mean BMI of 46.84 ±
8.5 kg/m2 (women: 46.4±8.1 kg/m2; men: 47.8±9.2 kg/m2).
Approximately 35% of the participants had type 2 diabetes
(T2DM), 37% metabolic syndrome (metabolic syndrome as
defined by the International Diabetes Federation definition,
IDF, [25]), and 29% a diagnosis of clinical depression. Patient
characteristics and distribution of participants by BMI
group, gender and presence of comorbidities are presented
in Table 1.
A non-parametric distribution was noted for BMI and
HAQ score in the study cohort. HAQ scores by BMI group,
gender, and comorbidities are presented in Table 2. The
median value of the HAQ score for the entire study cohort
was 0.375 (range: 0–2.65) and an increase in the HAQ score
was noted with increasing BMI. The Kruskal-Wallis test
revealed statistically significant difference in the HAQ score
between the three BMI groups (P < 0.001). The Mann-
Whitney test was used to compare HAQ scores between the
different pairs of BMI groups showing that (1) Group II
had a significantly higher HAQ score compared to Group I
(P = 0.004); (2) Group III had a significantly higher HAQ
score compared to Group I (P < 0.001); (3) Group III
had a significantly higher HAQ score compared to Group
II (P < 0.001) (Figure 1). Spearman’s correlation showed
that there was a significant correlation between HAQ score
and BMI (r = 0.420, P < 0.001), as well as between HAQ
score and age (r = 0.208, P = 0.001). After controlling for
age, the correlation between HAQ score and BMI remained
significant (P < 0.001).
Healthy individuals consistently score zero on the HAQ
[23], thus, an analysis was performed by dichotomizing the
study cohort based on the HAQ score to patients with no
disability (HAQ score: 0) and patients with at least some
degree of disability (HAQ score > 0). Of all study partici-
pants, 72.5% had HAQ scores higher than zero, reporting at
least a mild degree of difficulty in activities of daily living.
The prevalence rates of this degree of disability (HAQ score
> 0) between the different patient groups were compared
and tested for statistical significance by chi-square test. Based
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Figure 1: Health Assessment Questionnaire (HAQ) scores (median,
range) across the three body mass index (BMI) study groups
(Group I: 35–39.99 kg/m2; Group II: 40–44.99 kg/m2; Group III:
≥45.0 kg/m2). ∗Group III versus Group I (P < 0.001); ‡Group III
versus Group II (P < 0.001); †Group II versus Group I (P = 0.004).
on Pearson chi-square test, the prevalence rate of disability
(HAQ score > 0) was related to BMI and to the presence
of T2DM, metabolic syndrome, and depression, while it was
not related to gender. Indeed, the prevalence rate of disability
(HAQ score > 0) was significantly higher: (1) among
participants with a higher BMI (51.7% for Group I versus
66.2% for Group II versus 85.5% for Group III, P < 0.001,
Table 3); (2) among participants with T2DM (81.5% versus
67.6% in nondiabetic participants, P = 0.016); (3) among
participants with metabolic syndrome (79.6% versus 68.3%
in participants without metabolic syndrome, P = 0.047); (4)
among participants with clinical depression (85.75% versus
67% in nondepressed participants, P = 0.002). Table 3
also presents the distribution of participants across the three
BMI study groups when the HAQ score is categorized into
4 grades: (1) HAQ: 0 (no disability); (2) HAQ: 0.1–0.99
(mild to moderate difficulty); (3) HAQ: 1–1.99 (moderate
to severe disability); (4) HAQ: 2-3 (severe to very severe
disability). Logistic regression modelling in this study cohort
showed that BMI was associated with an odds ratio (OR)
of 1.128 (95% CI: 1.075–1.184; P < 0.001) for disability
(HAQ score > 0) adjusted for age and with an OR of 1.127
(95% CI: 1.073–1.185; P < 0.001) adjusted for both age and
depression. T2DM and metabolic syndrome when entered
as covariates into the logistic regression model did not have
a statistically significant effect to the model. These obesity-
related comorbidities were considered intermediaries in and
not confounders to the association between increased BMI
and disability, since based on the exclusion criteria of this
study, patients with disability attributed to further secondary
complications of cardio-metabolic disease (e.g., diabetic
foot ulcers, symptomatic diabetic neuropathy, Charcot’s
arthropathy, symptomatic ischemic heart disease, and heart
failure) were excluded.
Finally, the prevalence rates of having at least some
difficulty in standing (score > 0) and in walking more than
100 meters (score > 0) between the different patient groups
4 Journal of Obesity
Table 1: Selected patient characteristics and patient distribution by body mass index (BMI) group, gender, and presence of comorbidities.
Characteristics
BMI group
Total (N = 262)Group I
35–39.99 kg/m2
(N = 60)
Group II
40–44.99 kg/m2
(N = 71)
Group III
≥45 kg/m2
(N = 131)
BMI (kg/m2)
Range 35.1–39.8 40.2–44.9 45.1–77.9 35.1–77.9
Median 37.93 42.53 51.07 45.01
Mean (SD) 37.68 (1.42) 42.55 (1.39) 53.37 (7.1) 46.84 (8.5)
Age (years)
Range 22–69 22–75 21–66 21–75
Median 45 47 44 45
Mean (SD) 46 (9.9) 46 (10.8) 43.9 (10.6) 44.9 (10.5)
Gender
Men
17 18 44 79
[28.33%] [6.48%] [25.35%] [6.87%] [33.59%] [16.8%] [30.15%]
Women
43 53 87 183
[71.67%] [16.41%] [74.64%] [20.23%] [66.41%] [33.20%] [69.85%]
T2DM
No
38 46 86 170
[63.33%] [14.50%] [64.79%] [17.55%] [65.64%] [32.82%] [64.88%]
Yes
22 25 45 92
[36.66%] [8.39%] [35.21%] [9.54%] [34.35%] [17.17%] [35.12%]
MetS
No
39 43 82 164
[65%] [14.88%] [60.56%] [16.41%] [62.59%] [31.29%] [62.59%]
Yes
21 28 49 98
[35%] [8.02%] [39.44%] [10.69%] [37.40%] [18.70%] [37.41%]
Depression
No
47 51 87 185
[78.33%] [17.93%] [71.83%] [19.46%] [66.41%] [33.20%] [70.61%]
Yes
13 20 44 77
[21.66%] [4.96%] [28.17%] [7.64%] [33.59%] [16.79%] [29.39%]
Figures in brackets indicate % of each BMI category and % of total cohort, respectively.
SD: standard deviation; T2DM: type 2 diabetes mellitus; MetS: metabolic syndrome.
were also compared and tested for statistical significance.
Based on Pearson chi-square test, the prevalence rate of
difficulty in standing (score > 0) was related to BMI and to
the presence of T2DM, while it was not related to gender,
metabolic syndrome, and depression. Thus, the prevalence
rate of having at least some difficulty in standing was
significantly higher: (1) among participants with a higher
BMI (8.3% for Group I, 27.1% for Group II, 24.8% for
Group III, P = 0.016); (2) among participants with T2DM
(30.8% versus 16.7% in non-diabetic participants, P =
0.008). Furthermore, the prevalence rate of difficulty in
walking more than 100 meters (score > 0) was related to
BMI and to the presence of depression, while it was not
related to gender, T2DM, and metabolic syndrome. Indeed,
the prevalence rate of having at least some difficulty in
walking more than 100 meters was significantly higher: (1)
among participants with a higher BMI (18.6% for Group I,
44.1% for Group II, 53.2% for Group III, P < 0.001);
(2) among participants with depression (58.6% versus 36.5%
in nondepressed participants, P = 0.001).
4. Discussion
The primary objective of this study was to explore associa-
tions between obesity and self-reported disability in adults
with BMI ≥35 kg/m2. The data from our cohort of patients
with severe obesity showed that self-reported disability, as
expressed by the HAQ score, correlated with BMI, age, and
the presence of T2DM, metabolic syndrome, and clinical
depression. This finding agrees with data from the literature
that have documented the burden of disability in general and
obese populations, as well as in various other patient groups
[26–39].
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Table 2: Health Assessment Questionnaire (HAQ) disability index scores by body mass index (BMI) group, gender, and comorbidities.
Characteristics
BMI group
TotalGroup I Group II Group III
35–39.99 kg/m2 40–44.99 kg/m2 ≥45 kg/m2
All patients
N [%] 60 [22.9%] 71 [27.1%] 131 [50%] 262 [100%]
HAQ:
Range 0–1.75 0–2.5 0–2.625 0–2.65
Median 0.125 0.375 0.75 0.375
Mean (SD) 0.202 (0.29) 0.515 (0.61) 0.842 (0.67) 0.607 (0.64)
Men
N [%] 17 [6.48%] 18 [6.87%] 44 [16.8%] 79 [30.15%]
HAQ:
Range 0–0.625 0–2.125 0–2.5 0–2.5
Median 0.125 0.3125 0.875 0.5
Mean (SD) 0.206 (0.22) 0.388 (0.55) 0.954 (0.63) 0.664 (0.64)
Women
N [%] 43 [16.41%] 53 [20.23%] 87 [33.20%] 183 [69.85%]
HAQ:
Range 0–1.75 0–2.5 0–2.625 0–2.65
Median 0.0 0.375 0.625 0.375
Mean (SD) 0.2 (0.32) 0.559 (0.63) 0.785 (0.69) 0.582 (0.65)
Non T2DM
N [%] 38 [14.50%] 46 [17.55%] 86 [32.82%] 170 [64.88%]
HAQ:
Range 0–0.75 0–2.5 0–2.5 0–2.5
Median 0.0 0.25 0.625 0.3125
Mean (SD) 0.134 (0.2) 0.407 (0.54) 0.729 (0.65) 0.509 (0.6)
T2DM
N [%] 22 [8.39%] 25 [9.54%] 45 [17.17%] 92 [35.12%]
HAQ:
Range 0–1.75 0–2.0 0–2.625 0–2.625
Median 0.375 0.5 1.0 0.5625
Mean (SD) 0.318 (0.38) 0.715 (0.71) 1.058 (0.66) 0.788 (0.68)
Non MetS
N [%] 39 [14.88%] 43 [16.41%] 82 [31.29%] 164 [62.59%]
HAQ:
Range 0–1.75 0–2.5 0–2.25 0–2.5
Median 0.0 0.25 0.5625 0.375
Mean (SD) 0.163 (0.31) 0.424 (0.54) 0.698 (0.61) 0.499 (0.58)
MetS
N [%] 21 [8.02%] 28 [10.69%] 49 [18.70%] 98 [37.41%]
HAQ:
Range 0–0.625 0–2.0 0–2.625 0–2.625
Median 0.375 0.5 1.0 0.5625
Mean (SD) 0.273 (0.23) 0.656 (0.7) 1.084 (0.7) 0.788 (0.71)
Nondepressed
N [%] 47 [17.93%] 51 [19.46%] 87 [33.2%] 185 [70.61%]
HAQ:
Range 0–0.75 0–2.5 0–2.375 0–2.5
Median 0.0 0.25 0.5 0.375
Mean (SD) 0.154 (0.2) 0.485 (0.63) 0.686 (0.61) 0.495 (0.58)
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Table 2: Continued.
Characteristics
BMI group
TotalGroup I Group II Group III
35–39.99 kg/m2 40–44.99 kg/m2 ≥45 kg/m2
Depression
N [%] 13 [4.96%] 20 [7.64%] 44 [16.79%] 77 [29.39%]
HAQ:
Range 0–1.75 0–2.125 0–2.625 0–2.625
Median 0.375 0.5 1.25 0.75
Mean (SD) 0.375 (0.47) 0.593 (0.59) 1.150 (0.7) 0.875 (0.71)
Figures in brackets indicate % of total cohort.
SD: standard deviation; T2DM: type 2 diabetes mellitus; MetS: metabolic syndrome.
Table 3: Prevalence rates of degrees of disability based on the Health Assessment Questionnaire (HAQ) score across the three body mass
index (BMI) study groups (no disability (HAQ score: 0); at least some degree of disability (HAQ score > 0); mild to moderate difficulty
in performing daily life activities (HAQ score: 0.1–0.99); moderate to severe disability (HAQ score: 1–1.99); severe to very severe disability
(HAQ score: 2-3).
HAQ grade
BMI group
Total (N = 262)Group I
35–39.99 kg/m2
(N = 60)
Group II
40–44.99 kg/m2
(N = 71)
Group III
≥45 kg/m2
(N = 131)
HAQ: 0
N 29 24 19 72
% within HAQ grade 40.3% 33.3% 26.4% 100.0%
% within BMI group 48.3% 33.8% 14.5% 27.5%
% of total 11.1% 9.2% 7.3% 27.5%
HAQ: >0
N 31 47 112 190
% within HAQ grade 16.3% 24.7% 58.9% 100.0%
% within BMI group 51.7% 66.2% 85.5% 72.5%
% of total 11.8% 17.9% 42.7% 72.5%
HAQ: 0.1–0.99
N 30 33 60 123
% within HAQ grade 24.4% 26.8% 48.8% 100.0%
% within BMI group 50.0% 46.5% 45.8% 46.9%
% of total 11.5% 12.6% 22.9% 46.9%
HAQ: 1–1.99
N 1 11 42 54
% within HAQ grade 1.9% 20.4% 77.8% 100.0%
% within BMI group 1.7% 15.5% 32.1% 20.6%
% of total 0.4% 4.2% 16.0% 20.6%
HAQ: 2-3
N 0 3 10 13
% within HAQ grade 0.0% 23.1% 76.9% 100.0%
% within BMI group 0.0% 4.2% 7.6% 5.0%
% of total 0.0% 1.1% 3.8% 5.0%
The mean HAQ score for our study population was
0.607 (95% CI: 0.528–0.686) with a median value of 0.375
(range: 0–2.65). Krishnan et al. have reported normative
values for the HAQ disability index in the general population
in Finland, documenting a population mean HAQ score of
0.25 (95% CI: 0.22–0.28), with 32% of respondents having
at least some disability (HAQ score > 0) [26]. Given that
healthy individuals consistently score zero on the HAQ [23]
and that the HAQ score distribution is not Gaussian, we also
applied zero as a cut point for the HAQ score in order to
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dichotomize our study cohort into patients without disability
and patients with at least some difficulty in activities of daily
living. In this analysis, 72.5% of our study participants had
HAQ scores higher than zero. This is in accord with the
analysis of the data from Finland showing that within the
studied general population, which included approximately
20% obese participants (BMI >30 kg/m2), individuals with
BMI ≤30 kg/m2 had a significantly lower prevalence rate of
disability compared with obese individuals (HAQ score >
0: 28.4% versus 51.7% for nonobese and obese individuals,
resp.) [26]. Of note, in our study the prevalence rate of
disability (HAQ score > 0) was 51.7% in Group I, 66.2%
in Group II, and 85.5% in Group III, further documenting
a gradient of increasing self-reported disability as BMI
increases over 35 kg/m2. Indeed, comparing the HAQ score
for the three study BMI groups, we found that Group III
had significantly higher HAQ score compared with the other
two groups, while Group II had also significantly higher
HAQ score compared with Group I. The recognition of this
gradient may be useful in clinical practice for identifying
obese individuals with greater difficulty in performing
everyday tasks and could also allow further stratification of
patients in order to intensify interventions and prioritize the
use of available healthcare resources.
It must be noted that different cut points can be used to
define or categorize disability based on the HAQ disability
index score [40, 41]. HAQ scores up to 1 are generally
considered to reflect mild to moderate difficulty in daily life
activities, while scores between 1 and 2 represent moderate
to severe disability, and scores of 2 to 3 indicate severe to
very severe disability [40]. A study by Walter et al., exploring
the effects of obesity on mortality and disability in the older
population in The Netherlands, has used a cut point of 0.5
to define a participant as at least mildly disabled [27], as
previously applied for participants in the Rotterdam study
cohort [33]. The results of this study in older adults (age
55 years and older) also documented that BMI was related
to self-reported disability, with more years lost to disability
with increasing body weight, supporting our study findings.
Of note, applying zero as a cut point for the HAQ score
in the context of obesity provides a distinct measure to
dichotomize patients for the presence of disability, which
is not affected by the dispersion of the HAQ score within
different BMI categories and hence may be suggested as
a less controversial method than using any other cut-off
value. Furthermore, this cut point can also be regarded
as a treatment goal for weight loss interventions. Thus, a
notion of recovery from obesity-related disability could be
advocated similarly to remission/resolution of T2DM with
weight loss. Interestingly, studies in patients with rheumatoid
arthritis have documented that HAQ disability index scores
needed to improve by approximately −0.22 units before
participants stopped rating themselves as about the same
(minimally clinically important difference) [41]. In patients
with severe obesity, further research is required to evaluate at
what extent weight loss is associated with clinically meaning-
ful differences in physical functioning/disability scores and
whether certain weight loss interventions (e.g., diet, exercise,
cognitive behavioral therapy, pharmacotherapy, bariatric
surgery, and their combinations) might differ regarding such
functional/health status outcomes [42].
In addition to BMI, the HAQ score in our study also
correlated with age, which is consistent with available data
from the general population [26, 39]. However, in this
study cohort no relation was noted between the HAQ score
and gender, contrary to published evidence indicating that
activities of daily living may be more affected in women,
especially in older populations [27, 43–45]. This could be
partly attributed to a referral bias of obese patients with
higher disability independently of gender. Krishnan et al. also
reported that disability among women increased at a faster
rate compared to that among men and that women had a
higher estimated mean HAQ score (0.28 versus 0.18 in men)
[26]. Yet, also in this study, which included 1530 adults, this
gender difference was no longer statistically significant after
adjustment for age.
Finally, in our cohort of severely obese patients the
HAQ score was related to the presence of T2DM, metabolic
syndrome, and clinical depression. Central obesity is a
prerequisite for the IDF metabolic syndrome definition
[25], and T2DM is pathogenetically linked to obesity [46].
In addition, for the purposes of this study patients with
disability due to secondary complications of T2DM and/or
metabolic syndrome (e.g., diabetic foot ulcers, symptomatic
diabetic neuropathy, Charcot’s arthropathy, symptomatic
ischemic heart disease, and heart failure) were excluded.
Hence, these comorbidities were regarded as intermediaries
in and not confounders to the association between increased
BMI and disability and when entered as covariates into
the logistic regression models of this study did not have a
statistically significant effect. Contrary, the published data
regarding the association between obesity and depression is
less strong and mixed [47–51]. Therefore, depression was
entered as a covariate in the applied logistic regression model
which showed that, adjusted for both age and depression,
BMI was associated with an OR of 1.127 (95% CI: 1.073–
1.185; P < 0.001) for disability (HAQ score > 0).
5. Limitations of the Study
A limitation of this study is that the functional ability
of participants was self-reported. However, the HAQ is a
well-validated instrument, which is considered to accurately
document the existing degree of disability and is widely
applied in research. Furthermore, the HAQ can be regarded
as a generic measure to quantify functional impairment,
rather than disease specific for obesity. A similar validated
and established obesity-specific instrument for self-reporting
difficulty in daily life activities is currently lacking. On
the other hand, a relative advantage of applying a generic
measure is that it allows a degree of comparability between
obtained results and available data from the general popula-
tion and from patient groups with other diseases associated
with disability.
In this study, a random sample of the outpatient
population followed at our specialist obesity clinics was
obtained, and the overall response rate was considered
adequate. However, the nonresponse behaviour of severely
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obese patients attending an obesity clinic may not be
random but, rather, informative. In this case, the group of
nonresponders may have had either lower or higher HAQ
scores compared with respondents, resulting in an overall
disability rate for the study cohort, which would be either an
over- or underestimation, respectively. Overestimation of the
disability prevalence among patients followed at an obesity
clinic may also result from a referral bias due to higher
referring rates of patients with more complications from pri-
mary to secondary care. Conversely, under-estimation could
result from a different referral bias due to earlier/prompt
referrals of obese patients to secondary care in order to
prevent obesity-related complications. Such limitations are
relatively common in this type of research; however, among
the strengths of our study is the accurate assessment of BMI
for all participants, since these study data were not self-
reported, but were obtained through standardized clinical
measurements of body weight and height at the included
clinics.
Finally, a cause and effect relationship between obesity
and disability cannot be determined from this cross-sectional
study, and large, prospective studies are required to establish
such a relationship.
6. Conclusion
Our study focuses on associations between severe obesity and
functional limitations in activities of daily living. This aspect
of the disease has not received adequate attention, despite
robust evidence showing a growing burden of obesity-related
disability. Almost three quarters of our study population
reported at least some difficulty in performing daily life activ-
ities, and higher disability was documented with increasing
BMI, age, and presence of T2DM, metabolic syndrome,
and clinical depression. Such data can compliment current
systems of obesity classification which are mainly based
on anthropometric measures and do not offer direct infor-
mation on comorbid disease. Indeed, clinical and func-
tional staging systems for obesity are required to describe
the morbidity and functional limitations associated with
increased BMI in order to improve decision making in the
clinical practice [52]. For this purpose, disability assessment
should be an integral part of obesity management, including
patients that have failed to achieve significant weight loss.
Thus, healthcare providers would be able to provide rec-
ommendations based on the functional status of patients in
order to increase regular physical activity according to their
abilities and avoid complete inactivity. For instance, exercises
that mainly promote flexibility and functionality could be
recommended to severely obese individuals in order to
improve their ability to perform common daily life activities
and accommodate their work-specific functional needs (e.g.,
focus on improving coordination, balance, motion rage,
cardiovascular, and muscle fitness). Furthermore, data on
obesity-related disability could support practical strategies to
create an obese friendly workplace (e.g., appropriate chairs
and personal protective equipment) and built environment
(e.g., easy access and use not only of medical facilities
but also of services such as public transportation systems,
community centres, parks, and green spaces) in order to
encourage physical activity, work, and social engagement.
Finally, potentially contributing factors such as depression,
anxiety, low self-esteem, and social exclusion should be also
identified and addressed in the context of a holistic approach
to combat obesity-related disability and advance the care of
obese patients.
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